Almirall Valuation Multiples

Almirall Overview

About Almirall

Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.

Founded

1944

HQ

Employees

1.9K

Website

almirall.es

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $1B

EBITDA: $289M

EV

$3B

Valuation Multiples

Multiples.vc

Start free trial

Almirall Financials

Almirall reported last 12-month revenue of $1B and EBITDA of $289M.

In the same LTM period, Almirall generated $868M in gross profit, $289M in EBITDA, and $67M in net income.

Almirall P&L

In the most recent fiscal year, Almirall reported revenue of $1B and EBITDA of $275M.

Almirall expects next 12-month revenue of XXX and NTM EBITDA of XXX

Almirall Stock Performance

Almirall has current market cap of $3B, and enterprise value of $3B.

Almirall's stock price is $14.83.

Almirall Valuation Multiples

Almirall trades at 2.4x EV/Revenue multiple, and 11.0x EV/EBITDA.

Almirall Financial Valuation Multiples

As of April 10, 2026, Almirall has market cap of $3B and EV of $3B.

Equity research analysts estimate Almirall's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Almirall has a P/E ratio of 47.4x.

Almirall Margins & Growth Rates

Almirall's revenue in the last 12 month grew by 10%.

Almirall's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.5M for the same period.

Almirall's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Almirall's rule of X is 52% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Almirall Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Almirall M&A Activity

Almirall acquired XXX companies to date.

Last acquisition by Almirall was on XXXXXXXX, XXXXX. Almirall acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Almirall Investment Activity

Almirall invested in XXX companies to date.

Almirall made its latest investment on XXXXXXXX, XXXXX. Almirall invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).